-+ 0.00%
-+ 0.00%
-+ 0.00%

Belite Bio Q3 EPS $(0.65) Beats $(0.80) Estimate

Benzinga·11/12/2026 11:01:47
Listen to the news
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.80) by 18.75 percent. This is unchanged from the same period last year.